Lightbridge corp (LTBR)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating Activities:
Net Loss

-9,740

-10,587

-12,081

-13,855

-14,065

-15,676

-14,441

-11,960

-10,081

-7,104

-8,326

-8,096

-7,755

-6,345

-6,376

-5,047

-4,770

-4,318

332

602

-128

-3,654

-6,028

-7,443

-6,716

-4,587

-4,320

-4,248

-4,539

-4,057

-5,258

-5,179

-5,026

-5,869

0

0

0

Adjustments to reconcile net loss from operations to net cash used in operating activities:
Stock-based compensation

493

822

1,020

1,530

1,441

2,379

2,546

2,187

2,236

1,193

1,639

1,861

2,028

1,984

1,807

1,649

1,985

1,881

1,072

939

304

282

283

244

242

329

417

557

771

975

1,196

1,356

1,459

1,513

0

0

0

Amortization of deferred financing cost

-

-

-

-

-

-

-

-

-

491

491

436

314

191

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Write off of deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equity in loss from joint venture

-

-

-

-

0

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17

21

26

28

28

29

27

25

26

0

0

0

Loss on marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

0

-2

-45

-49

4

40

104

195

127

118

219

93

0

0

0

Warrant revaluation

-

-

-

-

-

-

-

-

-

-

-

-

-

1,672

1,208

2,213

2,361

2,306

5,117

4,891

4,335

1,162

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Write off of deferred financing costs

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equity in loss from joint venture

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating working capital items:
Accounts receivable - fees and reimbursable project costs

-

-

-

-

-

10

761

765

689

378

-68

-58

-66

248

-171

-177

-164

-329

117

-161

-189

43

-490

-254

89

-175

208

-1

-507

324

-416

-626

20

-713

0

0

0

Other receivable from joint venture

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued liabilities

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other receivable from joint venture

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other receivable from joint venture

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

-

-

-

-

-

-

-56

-77

-149

10

-37

-58

-311

-87

22

-14

156

-37

-187

-135

-142

-83

-148

-182

-244

-285

-257

-113

248

184

189

-298

-858

-95

0

0

0

Accounts payable and accrued liabilities

-

-

-

-

-

-

233

462

222

159

427

-178

-325

101

176

724

864

292

218

-402

-50

177

107

431

243

91

-812

-507

-1,018

-1,295

-260

-476

-417

-337

0

0

0

Deferred lease abandonment liability

-

-

-

-

-

-

-

-

-

-185

133

181

210

263

198

154

95

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-98

0

0

0

Net Cash Used In Operating Activities

-7,140

-6,667

-6,240

-7,109

-7,116

-7,421

-6,713

-5,721

-5,715

-5,003

-5,654

-6,087

-5,801

-5,976

-5,020

-4,286

-3,936

-3,650

-3,420

-3,453

-3,875

-4,315

-4,062

-4,530

-4,323

-3,916

-4,647

-4,097

-4,603

-5,053

-4,194

-4,044

-4,276

-4,050

0

0

0

Investing Activities:
Investment in joint venture

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investment in joint venture

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Patent costs

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investment in joint venture

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the sale of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,408

0

0

0

Purchase of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38

31

146

189

234

5,242

5,121

5,063

5,000

0

0

0

Purchase of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Patent costs

-

-

-

-

-

-

-

-46

259

207

197

227

191

209

228

164

159

117

91

119

127

134

129

90

90

98

91

97

69

63

97

153

165

159

0

0

0

Net Cash Used In Investing Activities

-2,216

-3,761

-4,125

-4,139

-2,063

-5,826

-5,437

-5,448

-5,476

-207

-197

-227

-191

-209

-228

-164

-159

-117

-77

-104

-112

-119

-129

975

1,460

1,434

4,449

3,857

3,720

3,681

-4,521

3,578

3,229

5,247

0

0

0

Financing Activities:
Net proceeds from the issuance of common stock

0

-

-

-

0

-

-

-

23,936

6,027

6,880

6,169

7,552

6,135

3,748

3,162

1,567

171

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from the issuance of preferred stock

-

-

-

-

-

-

-

-

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the issuance of note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

135

135

135

135

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

135

107

66

26

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-211

-211

-211

-290

0

0

-230

-230

-229

-229

1

1

1

1

1

1

1

1

1

1

1

1

0

0

0

Net Cash Provided by Financing Activities

2,163

3,750

5,619

6,517

10,734

33,369

33,265

32,884

27,950

6,141

6,853

8,822

10,456

9,147

6,787

3,563

1,675

170

4,733

4,941

4,983

4,983

4,270

3,956

3,956

3,956

-9

-1

0

-0

0

0

-1

-1

0

0

0

Net Decrease In Cash and Cash Equivalents

-7,193

-6,678

-4,746

-4,731

1,554

20,121

21,114

21,715

16,758

930

1,000

2,508

4,463

2,961

1,538

-887

-2,420

-3,597

1,234

1,383

994

547

78

401

1,094

1,475

-206

-241

-882

-1,371

-8,715

-466

-1,048

1,195

0

0

0

Cash and Cash Equivalents, Beginning of Period

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash and Cash Equivalents, End of Period

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid during the year
Interest paid

-

-

-

-

-

-

-

-

-

-

-

-

-

2

2

1

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Income taxes paid

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Non-Cash Financing Activities:
Deemed dividend on Series B convertible preferred stock due to beneficial conversion feature

-

-

-

-

-

-

-

-

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated preferred stock dividend

707

699

837

780

677

649

463

393

371

276

194

178

129

80

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of Series A convertible preferred stock to common stock and payment of paid-in-kind dividends to Series A preferred stockholder

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in accrued liabilities - stock-based compensation

-

-

-

-

-

-

-

-

-

121

121

121

121

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-